NCOA5 (Nuclear Receptor Coactivator 5, NCoA-5, Coactivator Independent of AF-2, CIA, KIAA1637, bA465L10.6)

619 EUR

100ug

GEN641611

N/A

NCOA5

IgG2b,k

Antibodies

Monoclonal

1000000000

ELISA (EL/EIA)

Mnoclonal antibodies

Human (Homo sapiens)

Mouse (Mus musculus)

Supplied as a liquid in PBS, pH 7.2.

NCOA5; NCOA5; CIA; bA465L10.6; KIAA1637; NCoA-5; CIA

NCOA5; NCOA5; CIA; bA465L10.6; KIAA1637; NCoA-5; CIA

NCOA5; NCOA5; CIA; bA465L10.6; KIAA1637; NCoA-5; CIA

Affinity Purified by Protein A affinity chromatography.

Human (Homo sapiens); Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby.

nuclear receptor coactivator 5; Nuclear receptor coactivator 5; nuclear receptor coactivator 5; NCoA-5; coactivator independent of AF-2; nuclear receptor coactivator 5; Coactivator independent of AF-2

Recognizes human NCOA5.; Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited. This particular antibody might cross react with speacies outside of the listed ones.

Store the antibody at +4 degrees Celsius for short term storage.. Aliquot to avoid repeated freezing and thawing. For optimal long term storage, the antibody should be kept at -20 degrees Celsius. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.